Clinical Trials Browser

Recruiting × OTHER × HER2-positive Gastric Cancer × Clear all

NCT06572319 2024-08-27

Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens

Phase 1/2 Recruiting

Gastrointestinal

HER2-positive Gastric Cancer